These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 17502066

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Natural killer cell-based immunotherapeutic strategies.
    Klingemann HG.
    Cytotherapy; 2005; 7(1):16-22. PubMed ID: 16040380
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Stimulating natural killer cells to protect against cancer: recent developments.
    Gillgrass A, Ashkar A.
    Expert Rev Clin Immunol; 2011 May; 7(3):367-82. PubMed ID: 21595603
    [Abstract] [Full Text] [Related]

  • 6. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M, Hachimine K, Huang J, Shibaguchi H, Kinugasa T, Maekawa S, Kuroki M.
    Anticancer Res; 2005 May; 25(6A):3725-32. PubMed ID: 16302732
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Can NK cells be a therapeutic target in human cancer?
    Chan CJ, Andrews DM, Smyth MJ.
    Eur J Immunol; 2008 Nov; 38(11):2964-8. PubMed ID: 18979512
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects.
    Guo H, Qian X.
    Onkologie; 2010 Nov; 33(7):389-95. PubMed ID: 20631487
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HLA and KIR polymorphisms affect NK-cell anti-tumor activity.
    Passweg JR, Huard B, Tiercy JM, Roosnek E.
    Trends Immunol; 2007 Oct; 28(10):437-41. PubMed ID: 17825623
    [Abstract] [Full Text] [Related]

  • 17. The immunobiology of natural killer cells and bone marrow allograft rejection.
    Barao I, Murphy WJ.
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):727-41. PubMed ID: 14677112
    [Abstract] [Full Text] [Related]

  • 18. NK cell-based cancer immunotherapy.
    Stagg J, Smyth MJ.
    Drug News Perspect; 2007 Apr; 20(3):155-63. PubMed ID: 17520092
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.